Search

Your search keyword '"Cinca, Juan"' showing total 416 results
Start Over Author "Cinca, Juan" Publication Type Academic Journals
416 results on '"Cinca, Juan"'

5. Prevalence, clinical profile and prognostic implications of interatrial block in patients admitted for heart failure

Author

Álvarez-García, Jesús, Valero, María Jesús, Solé-González, Eduard, Ferrero-Gregori, Andreu, Vives-Borrás, Miquel, Vázquez-García, Rafael, González-Juanatey, José Ramón, García-Pavía, Pablo, Pascual-Figal, Domingo, Bover, Ramón, Bascompte, Ramón, Delgado, Juan, Bardají, Alfredo, Pérez-Villa, Félix, Zamorano, José Luis, Crespo-Leiro, María G., Sánchez, Pedro Luis, García-Osuna, Álvaro, Robledo-Escobar, Luis Alberto, de Luna, Antonio Bayés, Martínez-Sellés, Manuel, and Cinca, Juan

Published
2020
Full Text
View/download PDF

7. Cambio en la causa de muerte e influencia de la mejora terapéutica con el tiempo en pacientes con insuficiencia cardiaca y fracción de eyección reducida

Author

Fernández-Vázquez, David, Ferrero-Gregori, Andreu, Álvarez-García, Jesús, Gómez-Otero, Inés, Vázquez, Rafael, Delgado Jiménez, Juan, Worner Diz, Fernando, Bardají, Alfredo, García-Pavía, Pablo, Bayés-Genís, Antoni, González-Juanatey, José R., Cinca, Juan, and Pascual Figal, Domingo A.

Published
2020
Full Text
View/download PDF

10. Patient-Associated Predictors of 15- and 30-Day Readmission After Hospitalization for Acute Heart Failure

Author

Delgado, Juan F., Ferrero Gregori, Andreu, Fernández, Laura Morán, Claret, Ramón Bascompte, Sepúlveda, Andrés Grau, Fernández-Avilés, Francisco, González-Juanatey, José R., García, Rafael Vázquez, Otero, Miguel Rivera, Segovia Cubero, Javier, Pascual Figal, Domingo, Crespo-Leiro, Maria G., Alvarez-García, Jesús, Cinca, Juan, and Ynsaurriaga, Fernando Arribas

Published
2019
Full Text
View/download PDF

14. Prognostic Impact of Physician Specialty on the Prognosis of Outpatients With Heart Failure: Propensity Matched Analysis of the REDINSCOR and RICA Registries

Author

Álvarez-García, Jesús, Salamanca-Bautista, Prado, Ferrero-Gregori, Andreu, Montero-Pérez-Barquero, Manuel, Puig, Teresa, Aramburu-Bodas, Óscar, Vázquez, Rafael, Formiga, Francesc, Delgado, Juan, Arias-Jiménez, José Luis, Vives-Borrás, Miquel, Cerqueiro González, J. Manuel, Manzano, Luis, and Cinca, Juan

Published
2017
Full Text
View/download PDF

16. Impacto pronóstico de la especialidad en el paciente ambulatorio con insuficiencia cardiaca: un análisis emparejado de los registros REDINSCOR y RICA

Author

Álvarez-García, Jesús, Salamanca-Bautista, Prado, Ferrero-Gregori, Andreu, Montero-Pérez-Barquero, Manuel, Puig, Teresa, Aramburu-Bodas, Óscar, Vázquez, Rafael, Formiga, Francesc, Delgado, Juan, Arias-Jiménez, José Luis, Vives-Borrás, Miquel, Cerqueiro González, J. Manuel, Manzano, Luis, and Cinca, Juan

Published
2017
Full Text
View/download PDF

32. Abstract 20565: Risk Stratification of Acute Heart Failure Based on a Multi-Biomarker Analysis at Admission and Hospital Discharge

Author

Álvarez-García, Jesús, García-Osuna, Álvaro, Ferrero-Gregori, Andreu, Vives-Borrás, Miquel, Margarida, Grau-Agramunt, Solé-González, Eduard, Rivera, Miguel, Pascual-Figal, Domingo, Alonso-Pulpón, Luis, Fernández-Avilés, Francisco, Juan, Delgado, González-Juanatey, José Ramón, Worner, Fernando, Vázquez, Rafael, Ordoñez-Llanos, Jordi, and Cinca, Juan

Published
2017

40. Time course, factors related to, and prognostic impact of venoarterial extracorporeal membrane flow in cardiogenic shock.

Author

Montero, Santiago, Rivas‐Lasarte, Mercedes, Huang, Florent, Chommeloux, Juliette, Demondion, Pierre, Bréchot, Nicolas, Hékimian, Guillaume, Franchineau, Guillaume, Persichini, Romain, Luyt, Charles‐Édouard, Garcia‐Garcia, Cosme, Bayes‐Genis, Antoni, Lebreton, Guillaume, Cinca, Juan, Leprince, Pascal, Combes, Alain, Alvarez‐Garcia, Jesus, and Schmidt, Matthieu

Subjects
CARDIOGENIC shock, ARTIFICIAL respiration, EXTRACORPOREAL membrane oxygenation, MYOCARDIAL infarction, INTENSIVE care units, VENTILATOR-associated pneumonia, ASPARTATE aminotransferase
Abstract

Aims: Venoarterial extracorporeal membrane oxygenation (VA‐ECMO) is currently one of the most used devices in refractory cardiogenic shock. However, there is a lack of evidence on how to set the 'optimal' flow. We aimed to describe the evolution of VA‐ECMO flows in a cardiogenic shock population and determine the risk factors of 'high‐ECMO flow'. Methods and results: A 7 year database of patients supported with VA‐ECMO was used. Based on the median flow during the first 48 h of the VA‐ECMO run, patients were classified as 'high‐flow' or 'low‐flow', respectively, when median ECMO flow was ≥3.6 or <3.6 L/min. Outcomes included rates of ventilator‐associated pneumonia, ECMO‐related complications, days on ECMO, days on mechanical ventilation, intensive care unit and hospitalization lengths of stay, and in‐hospital and 60 day mortality. Risk factors of high‐ECMO flow were assessed using univariate and multivariate cox regression. The study population included 209 patients on VA‐ECMO, median age was 51 (40–59) years, and 78% were males. The most frequent aetiology leading to cardiogenic shock was end‐stage dilated cardiomyopathy (57%), followed by acute myocardial infarction (23%) and fulminant myocarditis (17%). Among the 209 patients, 105 (50%) were classified as 'high‐flow'. This group had a higher rate of ischaemic aetiology (16% vs. 30%, P = 0.023) and was sicker at admission, in terms of worse Simplified Acute Physiology Score II score [40 (26–58) vs. 56 (42–74), P < 0.001], higher lactate [3.6 (2.2–5.8) mmol/L vs. 5.2 (3–9.7) mmol/L, P < 0.001], and higher aspartate aminotransferase [97 (41–375) U/L vs. 309 (85–939) U/L, P < 0.001], among others. The 'low‐flow' group had less ventilator‐associated pneumonia (40% vs. 59%, P = 0.007) and less days on mechanical ventilation [4 (1.5–7.5) vs. 6 (3–12) days, P = 0.009]. No differences were found in lengths of stay or survival according to the ECMO flow. The multivariate analysis showed that risk factors independently associated with 'high‐flow' were mechanical ventilation at cannulation [odds ratio (OR) 3.9, 95% confidence interval (CI) 2.1–7.1] and pre‐ECMO lactate (OR 1.1, 95% CI 1.0–1.2). Conclusions: In patients with refractory cardiogenic shock supported with VA‐ECMO, sicker patients had higher support since early phases, presenting thereafter higher rates of ventilator‐associated pneumonia but similar survival compared with patients with lower flows. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results